Search results for "outcomes."

showing 10 items of 434 documents

Initial Experience with Radical Prostatectomy Following Holmium Laser Enucleation of the Prostate

2021

Background: Although an increasing number of prostate cancer (PCa) patients received holmium laser enucleation of the prostate (HoLEP) previously for benign prostatic obstruction (BPO), there is still no evidence regarding the outcomes of radical prostatectomy (RP) in this setting. Objective: To assess functional and oncological results of RP in PCa patients who received HoLEP for BPO previously in a contemporary multi-institutional cohort. Design, setting, and participants: A total of 95 patients who underwent RP between 2011 and 2019 and had a history of HoLEP were identified in two institutions. Functional as well as oncological follow-up was prospectively assessed and retrospectively an…

Malemedicine.medical_specialtyHolmium laser enucleation of the prostate; Localized prostate cancer; Patient-reported outcomes; Radical prostatectomy; Urinary continenceUrologymedicine.medical_treatmentEnucleation030232 urology & nephrologyUrologyProstatic HyperplasiaUrinary incontinenceLasers Solid-State03 medical and health sciencesBladder outlet obstructionProstate cancerHolmium0302 clinical medicineErectile DysfunctionmedicineHumansRetrospective StudiesProstatectomyLocalized prostate cancerPatient-reported outcomesProstatectomybusiness.industryHazard ratioProstateUrinary continenceOdds ratiomedicine.diseaseRadical prostatectomyHolmium laser enucleation of the prostate030220 oncology & carcinogenesisPropensity score matchingmedicine.symptombusiness
researchProduct

Impact of routine invasive strategy on outcomes in patients with non-ST-segment elevation myocardial infarction during 2005–2014: A report from the P…

2020

Background: Non-ST-segment elevation myocardial infarction (NSTEMI) has become the most frequently encountered type of myocardial infarction. The patient clinical profile and management has evolved over the past decade. As there is still a scarcity of data on the latest trends in NSTEMI, changes herein were observed and assessed in the treatment and outcomes in Poland between 2005 and 2014. Methods: A total of 197,192 patients with NSTEMI who enrolled in the Polish Registry of Acute Coronary Syndromes (PL-ACS) between 2005 and 2014 were analyzed. In-hospital and 12-month mortality were assessed. Results: Coronary angiography use increased from 35.8% in 2005–2007 to 90.7% in 2012–2014 (p < 0…

Malemedicine.medical_specialtyInvasive strategyMultivariate analysismedicine.medical_treatmentnon-ST-elevation myocardial infarctionMyocardial InfarctionClinical CardiologyoutcomesCoronary AngiographyVentricular Function Lefttemporal trendsPercutaneous Coronary InterventionRisk FactorsInternal medicinemedicineST segmentHumansinvasive strategyMyocardial infarctionRegistriesAcute Coronary SyndromeChildNon-ST Elevated Myocardial Infarctionbusiness.industryMortality ratePercutaneous coronary interventionStroke VolumeGeneral MedicineOdds ratioMiddle Agedmedicine.diseaseConfidence intervalTreatment OutcomeCardiologyFemalePolandCardiology and Cardiovascular Medicinebusiness
researchProduct

Acute Kidney Injury After Percutaneous Edge-to-Edge Mitral Repair.

2020

BACKGROUND In catheter-based procedures, acute kidney injury (AKI) is a frequent, serious complication ranging from 10% to 30%. In MitraClip (Abbott Vascular, Santa Clara, California), a usually contrast-free procedure, there is scarce data about its real incidence and impact. OBJECTIVES This study aimed to evaluate incidence, predictive factors, and midterm outcomes of AKI in patients with significant mitral regurgitation (MR) undergoing transcatheter valve repair with MitraClip. METHODS A total of 721 patients undergoing MitraClip were included. AKI was defined as an absolute or a relative increase in serum creatinine of >0.3 mg/dl or >= 50%, respectively, or the need for hemodialysis dur…

Malemedicine.medical_specialtyMitral Valve Annuloplastymedicine.medical_treatmentPopulationRenal function030204 cardiovascular system & hematologyoutcomesurologic and male genital diseasesrenal insufficiency03 medical and health sciences0302 clinical medicinePostoperative ComplicationsInterquartile rangeInternal medicinemedicineMitraClipHumans030212 general & internal medicinemitral edge-to-edge repaireducationAgedRetrospective StudiesAged 80 and overMitral regurgitationeducation.field_of_studybusiness.industryMitraClipIncidenceEndovascular ProceduresAcute kidney injuryMitral Valve InsufficiencyAcute Kidney InjuryMiddle AgedMitraClip acute kidney injury mitral edge-to-edge repair mortality outcomes renal insufficiencymedicine.diseasemortalityfemale genital diseases and pregnancy complicationsacute kidney injurySpainCardiologyFemaleHemodialysisCardiology and Cardiovascular MedicineComplicationbusiness
researchProduct

Impact of type and severity of postoperative complications on long‐term outcomes after colorectal liver metastases resection

2020

Background and objectives Postoperative complications (POCs) after hepatic resection for colorectal liver metastases (CRLM) adversely affect long-term survival. The aim of this study was to analyze the effect of POC etiology and severity on overall survival (OS) and disease-free survival (DFS). Methods A retrospective study of 254 consecutive hepatectomies for CRLM was performed. Univariate and multivariate analyses were performed to determine the effects of demographic, tumor-related and perioperative variables on OS and DFS. A 1:1 propensity score matching (PSM) was then used to compare patients with different POC etiology: infective (Inf-POC), noninfective (Non-inf POC), and no-complicat…

Malemedicine.medical_specialtyMultivariate analysisColorectal cancerGastroenterologyDisease-Free SurvivalResectionCohort Studies03 medical and health sciencesPostoperative Complications0302 clinical medicineInternal medicineparasitic diseasesLong term outcomesmedicineHepatectomyHumansPropensity ScoreAgedRetrospective Studiesbusiness.industryLiver NeoplasmsRetrospective cohort studyGeneral MedicinePerioperativeMiddle Agedmedicine.diseaseSurvival RateOncologySpain030220 oncology & carcinogenesisPropensity score matchingEtiologyFemale030211 gastroenterology & hepatologySurgeryColorectal NeoplasmsbusinessJournal of Surgical Oncology
researchProduct

Long-term clinical outcomes after drug-eluting stent implantation in unprotected left main coronary artery disease.

2009

Objective: To investigate long-term outcomes of unprotected left main coronary artery (ULMCA) disease treatment using drug-eluting stents (DES). Background: In several studies, DES implantation in ULMCA appeared safe and effective at mid-term; however, to date, there is limited long-term data. Methods: All consecutive patients undergoing sirolimus- or paclitaxel-eluting stent implantation in ULMCA disease at a single institution were evaluated. The primary endpoint was long-term major adverse cardiac events (MACE) defined as cardiac death, nonfatal myocardial infarction, or target lesion revascularization (TLR). Stent thrombosis (ST), according to Academic Research Consortium definitions, w…

Malemedicine.medical_specialtyPaclitaxelmedicine.medical_treatmentCoronary Artery DiseaseCoronary AngiographyRestenosisRecurrenceInternal medicineLong-term outcomes.medicineClinical endpointHumansRadiology Nuclear Medicine and imagingcardiovascular diseasesMyocardial infarctionSurvival rateAgedProportional Hazards ModelsSirolimusChi-Square Distributionbusiness.industryHazard ratioEuroSCOREDrug-Eluting StentsGeneral MedicineLeft main coronary arterymedicine.diseaseSurgeryTreatment OutcomeDrug-eluting stentCardiologyFemaleDrug-eluting stentCardiology and Cardiovascular MedicinebusinessMaceFollow-Up StudiesCatheterization and cardiovascular interventions : official journal of the Society for Cardiac AngiographyInterventions
researchProduct

Robotic-assisted pancreaticoduodenectomy with vascular resection. Description of the surgical technique and analysis of early outcomes

2019

Abstract Background Despite the potential benefits, the adoption of the minimally invasive surgery for the treatment of borderline resectable pancreatic cancer is still in the initial phase. We investigated the safety and feasibility of the robotic pancreaticoduodenectomy with venous resection/reconstruction (RPD SMV/PV). Methods Since March 2013 to October 2019, a total of 73 RPD and 10 RPD SMV/PV were performed. The two groups were case-matched according to the preoperative characteristics. Results Mean operative times and estimated blood loss were less in the RPD group in comparison to that in the RPD with SMV-PV group (525 vs 642 min, p = 0.003 and 290 vs 620 ml, p = 0.002, respectively…

Malemedicine.medical_specialtyRobotic assistedmedicine.medical_treatmentOperative TimeAdenocarcinoma030230 surgeryPancreaticoduodenectomy03 medical and health sciences0302 clinical medicineRobotic Surgical ProceduresBorderline resectablePancreatic cancerVascular reconstructionHumansMedicineRobotic surgeryVascular resectionAgedbusiness.industryMortality rateSurgical outcomesRobotic surgeryMiddle Agedmedicine.diseasePancreaticoduodenectomySurgeryPancreatic NeoplasmsTreatment OutcomeOncology030220 oncology & carcinogenesisInitial phaseFemaleSurgerybusinessVascular Surgical Procedures
researchProduct

Sex-specific differences drive temporal trends and outcomes of patients hospitalized for heart failure in Germany

2020

Despite remarkable improvements in treatment of cardiovascular disease, heart failure (HF) is still characterized by high mortality rate. Sex-specific differences in HF have been described, but underlying reasons are widely unexplored.The nationwide German inpatient sample (2005-2016) was used for this sex-specific analyses. Temporal trends on hospitalizations, mortality, and treatments were analysed and independent predictors of adverse outcomes identified.The analysis comprises 4,538,977 hospitalizations due to HF (52.0%women) in Germany (2005-2016). Although women were older (median 82(IQR75-87) vs.76(69-82),P  0.001), coronary artery disease (CAD, 50.3% vs. 30.7%,P  0.001) was more prev…

Malemedicine.medical_specialtyTime FactorsDatabases FactualAdverse outcomesMEDLINEDisease030204 cardiovascular system & hematologyRisk Assessment03 medical and health sciencesSex Factors0302 clinical medicineGermanyInternal medicineCase fatality ratePrevalencemedicineHumansHospital Mortality030212 general & internal medicineHealthcare DisparitiesAgedAged 80 and overHeart Failurebusiness.industryIncidenceMortality rateIncidence (epidemiology)Health Status Disparitiesmedicine.diseaseSex specificHospitalizationOutcome and Process Assessment Health CareTreatment OutcomeHeart Disease Risk FactorsHeart failureFemaleCardiology and Cardiovascular MedicinebusinessProgress in Cardiovascular Diseases
researchProduct

Differential Prognostic Value of Galectin-3 According to Carbohydrate Antigen 125 Levels in Transcatheter Aortic Valve Implantation

2019

Galectin-3 (Gal-3) and carbohydrate antigen 125 (CA125) have been associated with adverse outcomes after transcatheter aortic valve implantation (TAVI). Experimental data have suggested a potential molecular interaction. Therefore, we assessed the association of Gal-3 and CA125 with prognosis after TAVI.A total of 439 patients were enrolled. The primary endpoint was a composite of all-cause mortality or readmission for worsening heart failure after TAVI.The primary endpoint occurred in 16.4%. Gal-3 was dichotomized at ≥ 8.71 ng/mL into elevated and not elevated. Gal-3 was elevated in 31.9% and was associated with a higher risk of the primary endpoint (25% vs 12.4%, HR, 2.26; P.001). After m…

Malemedicine.medical_specialtyTranscatheter aorticAdverse outcomesGalectin 3030204 cardiovascular system & hematologyRisk AssessmentTranscatheter Aortic Valve Replacement03 medical and health sciences0302 clinical medicineRisk FactorsCause of DeathGermanyInternal medicinemedicineClinical endpointHumansIn patientAgedRetrospective StudiesAged 80 and overbusiness.industryAortic Valve StenosisGeneral MedicinePrognosismedicine.diseaseSurvival RateGalectin-3CA-125 AntigenHeart failureAortic valve stenosisCardiologyFemalebusinessCarbohydrate antigenBiomarkersFollow-Up StudiesRevista Española de Cardiología (English Edition)
researchProduct

Physical fitness in relation to later body composition in pre-school children

2019

Objectives Although physical fitness is considered a marker of health in youth, little is known whether physical fitness in pre-school age is related to later body composition. Thus, this study investigated (i) associations of physical fitness at 4.5 years of age with body composition 12 months later and (ii) whether improvements in physical fitness during the 12-month follow-up were associated with changes in body composition. Design This study included 142 children, measured at 4.5 and 5.5 years, from the control group of the MINISTOP trial. Methods Physical fitness (cardiorespiratory fitness, lower- and upper-body muscular strength and motor fitness) was measured using the PREFIT test ba…

Malemedicine.medical_specialtyair-displacement plethysmographyPhysical fitnessPhysical Therapy Sports Therapy and RehabilitationPhysical strengthHealth outcomesFat mass03 medical and health sciences0302 clinical medicineFat-free mass; Fat mass; Cardiorespiratory fitness; Muscular strength; Motor fitness; Pre-schoolMedicinePlethysmographHumansOrthopedics and Sports MedicineMass index030212 general & internal medicineMuscle Strengthta315Sport and Fitness SciencesAdiposityRandomized Controlled Trials as TopickehonkoostumusSwedenpre-schoolcardiorespiratory fitnessAnthropometrybusiness.industryIdrottsvetenskapCardiorespiratory fitnessta3141fat mass030229 sport sciencesfat-free massmotor fitnessMotor SkillsPhysical FitnessChild PreschoolesikouluikäisetPhysical therapyBody CompositionPre schoolFemalebusinessmuscular strengthfyysinen aktiivisuus
researchProduct

Efficacy of systemic administration of riboflavin on a rabbit model of corneal alkali burn

2020

AbstractChanges in the barrier mechanisms in the eye should determine the rational route for the administration and dosage of each drug in the treatment of traumatic injuries and other pathologies. The aim of this study was to examine the efficacy of intra-arterial delivery of 14C-riboflavin (as an “indicator”) and compare it with intravenous and intramuscular administration in an animal model of chemical eye burn. 14C-riboflavin (14C-I) was administered by intra-arterial (carotid artery), intravenous (femoral vein) and intramuscular (femoral muscle) routes. The total radioactivity was determined over 2 h in the plasma and structures of the rabbit’s eyes using a scintillation counter. The r…

Malemedicine.medical_specialtygenetic structuresRiboflavinFemoral veinlcsh:MedicineAlkaliesAdministration CutaneousInjections Intramuscular030226 pharmacology & pharmacyArticleCornea03 medical and health sciencesRoute of administrationMedical research0302 clinical medicineCiliary bodyOphthalmologyCorneaBurns ChemicalmedicineAnimalsHumanslcsh:ScienceMultidisciplinarybusiness.industryAqueous humourlcsh:Reye diseasesScleraDisease Models AnimalEye Burnsmedicine.anatomical_structureInjections Intra-ArterialOutcomes research030221 ophthalmology & optometrySystemic administrationlcsh:QFemaleRabbitssense organsChoroidbusinessCorneal InjuriesScientific Reports
researchProduct